2018
DOI: 10.1172/jci.insight.97440
|View full text |Cite
|
Sign up to set email alerts
|

CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
18
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 26 publications
(20 citation statements)
references
References 66 publications
(67 reference statements)
2
18
0
Order By: Relevance
“…5a). This result is consistent with previous studies showing that CHD7 both positively and negatively regulates expression of other genes 3,18,27 .…”
Section: Chd7 Regulates Genes Expression Chd7 Enrichment In the Genesupporting
confidence: 94%
“…5a). This result is consistent with previous studies showing that CHD7 both positively and negatively regulates expression of other genes 3,18,27 .…”
Section: Chd7 Regulates Genes Expression Chd7 Enrichment In the Genesupporting
confidence: 94%
“…In addition to the pharmacologic manipulation of RA levels, genetic alterations in RA signaling are important causes of congenital craniofacial and ocular defects (Adams & Lammer, 1995;de la Cruz et al, 1984;Lammer et al, 1985;Maden, 2001;Rosa et al, 1986). Mutations in genes that are important for regulating RA synthesis (ALDH1A3, OMIM:600463; CHD7, OMIM:608892), degradation (CYP26B1, OMIM:605207), transport (STRA6; OMIM:610745), and signaling (RARβ; OMIM:180220) have all been identified in congenital diseases (Aldahmesh et al, 2013;Casey et al, 2011;Chassaing et al, 2013;Fares-Taie et al, 2013;Golzio et al, 2007;Laue et al, 2011;Micucci et al, 2014;Pagon, Graham Jr., Zonana, & Young, 1981;Pasutto et al, 2007;Roos et al, 2014;Srour et al, 2013;Yahyavi et al, 2013;Yao et al, 2018) Further, known downstream targets of RA within neural crest cells, including RAI1 (OMIM:607642),…”
Section: Congenital Craniofacial and Ocular Diseases Resulting Frommentioning
confidence: 99%
“…Tbx1 is also responsive to Shh signaling in the pharyngeal endoderm (Yamagishi et al, 2003;Yamagishi et al, 2006), and in turn Shh expression is diminished in PAE embryos. CHARGE syndrome is a congenital condition caused by heterozygous loss-of-function of the chromodomain helicase DNA-binding protein (CHD7) gene (Vissers et al, 2004) that regulates downstream target gene expression via changes in nucleosome accessibility (Yao et al, 2018). Most of the CHARGE clinical features, including craniofacial malformations overlap with VAD syndrome (Maden, 2001), retinoic acid embryopathy (Lammer et al, 1985), and FASD phenotypes (Popova et al, 2016).…”
Section: Retinoic Acid Regulates Cncc Migrationmentioning
confidence: 99%